Over 6.8 million Americans have received the J&J COVID-19 vaccine, which is now facing renewed scrutiny after six of those recipients developed a rare, severe type of blood clot that has caused the FDA and Centers for Disease Control and Prevention (CDC) to recommend a pause in the rollout.
